Skip to main navigation
Avadel Pharmaceuticals
  • Recent News
  • Investors
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Business Development
    • Corporate Responsibility
  • Research
    • Clinical Trials
  • Contact Us
  • Call Today
  • Email Us
  • Our Map
    • Avadel Pharmaceuticals
    • 636.449.1830
    • Home
    • About
      • Overview
      • Leadership
      • Board of Directors
      • Business Development
      • Corporate Responsibility
    • Research Pipeline
      • Clinical Trials
    • Investor Relations

      • Investors
      • News & Events
        • Press Releases
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historical Price Lookup
        • Investment Calculator
        • Analyst Coverage
      • Financial Information
        • SEC Filings
        • Financial Reports
        • Quarterly Results
      • Corporate Governance
        • Governance Highlights
        • Management Team
        • Board of Directors
        • Committee Composition
        • Annual General Meeting
      • Shareholder Services
        • Investor FAQs
        • Information Request
        • E-mail Alerts
        • IR Contacts
    • Contact Us
646.449.1830

Breadcrumb

  1. Home
  2. Investors
  3. SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group Downloads
02/17/21 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-21-024673.rtf
0001104659-21-024673.xls
0001104659-21-024673.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
02/17/21 3

Initial filing by director officer or owner of more than ten percent.

3,4,5
0001179110-21-001778.rtf
0001179110-21-001778.xls
0001179110-21-001778.pdf
02/17/21 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-21-001780.rtf
0001179110-21-001780.xls
0001179110-21-001780.pdf
02/16/21 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
0001172661-21-000418.rtf
0001172661-21-000418.xls
0001172661-21-000418.pdf
02/12/21 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
0000902664-21-001237.rtf
0000902664-21-001237.xls
0000902664-21-001237.pdf
02/12/21 SC 13G/A

An amendment to the SC 13G filing

Other
0001493152-21-003505.rtf
0001493152-21-003505.xls
0001493152-21-003505.pdf
02/11/21 SC 13G/A

An amendment to the SC 13G filing

Other
0001104659-21-020718.rtf
0001104659-21-020718.xls
0001104659-21-020718.pdf
02/10/21 S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
0001104659-21-019878.rtf
0001104659-21-019878.pdf
01/25/21 UPLOAD

UPLOAD

Other
0000000000-21-000846.rtf
0000000000-21-000846.pdf
12/23/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-012216.rtf
0001179110-20-012216.xls
0001179110-20-012216.pdf
12/16/20 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-20-136015.rtf
0001104659-20-136015.xls
0001104659-20-136015.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
12/14/20 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-20-135320.rtf
0001104659-20-135320.xls
0001104659-20-135320.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
12/09/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-011792.rtf
0001179110-20-011792.xls
0001179110-20-011792.pdf
12/09/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-011791.rtf
0001179110-20-011791.xls
0001179110-20-011791.pdf
11/09/20 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-20-122748.rtf
0001104659-20-122748.xls
0001104659-20-122748.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
11/09/20 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
0001012477-20-000017.rtf
0001012477-20-000017.xls
0001012477-20-000017.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
09/21/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009897.rtf
0001179110-20-009897.xls
0001179110-20-009897.pdf
09/18/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009877.rtf
0001179110-20-009877.xls
0001179110-20-009877.pdf
09/18/20 4

Statement of changes in beneficial ownership of securities

3,4,5
0001179110-20-009879.rtf
0001179110-20-009879.xls
0001179110-20-009879.pdf
09/14/20 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-20-104616.rtf
0001104659-20-104616.xls
0001104659-20-104616.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Tools

  • Print Page
  • RSS
  • E-mail Alerts

Investor Relations

  • Investors
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
    • Annual General Meeting
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • IR Contacts

Contact Avadel Pharmaceuticals Today

Avadel Pharmaceuticals

Helpful Links Site Map | Privacy Policy | Terms and Conditions

  • Overview
  • News & Events
  • Careers
  • Investors
  • Contact Us
16640 Chesterfield Grove Road,
Suite 200,
Saint Louis, MO 63005 |  View Map [+]
http://www.avadel.com/
Site Map | Privacy Policy
http://www.avadel.com/

© COPYRIGHT AVADEL PHARMACEUTICALS, PLC. ALL RIGHTS RESERVED

0117 AVL WBST MAIN_KP2